Calcitriol and isotretinoin combined therapy for precancerous and cancerous skin lesions

References

• McCarthy D M, San Miguel J F, Freake H C., et al. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL 60) cells and induces monocyte-macrophage differentiation in HL 60 and normal human bone marrow cells. Leak Res 1983; 7: 51–5
   PubMed Web of Science ®Google Scholar
• Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37: 889–95
   PubMed Web of Science ®Google Scholar
• Smith E L, Walworth N C, Holick M F. Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions. J Invest Dermatol 1986; 86: 706–16
   PubMed Web of Science ®Google Scholar
• Rains V, Cunningham D, Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 1991; 63: 463–5
   PubMed Web of Science ®Google Scholar
• Frampton R J, Omond S A, Eisman J A. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D, metabolites. Cancer Res 1983; 43: 4443–7
   PubMed Web of Science ®Google Scholar
• Eisman A, Barkla D H, Tutton P JM. Suppression of in vivo growth of human cancer solid tumour xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 1987; 47: 21–5
   PubMed Web of Science ®Google Scholar
• Bollag W. New retinoids with potential use in humans. Retinoids: new trends in research and therapy., I H Saurat. Birkhauser Verlag, Basel 1985; 274–88, Retinoid Symposium
   Google Scholar
• Jetten A M, Kim S, Sacks P C, et al. Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by /?-all-trans retinoic acid. Int J Cancer 1990; 45: 195–202
   PubMed Web of Science ®Google Scholar
• Bollag W, Hartmann H R. Prevention and therapy of cancer with retinoids in animals and man. Cancer Surv 1983; 2: 293–314
   Google Scholar
• Lippman S M, Kessler J F, Meyskens F L., Jr. Retinoids as preventive and therapeutic anticancer agents. II. Cancer Treat Rep 1987; 71: 493–515
   PubMedGoogle Scholar
• Huang M E, Ye Y C, Chen S R., et al. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72
   PubMed Web of Science ®Google Scholar
• Majewski S, Skopinska M, Bollage W, et al. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 1994; 344: 1510–11
   Google Scholar
• Giguere V, Yang N, Petal Segui. Identification of a new class of steroid hormone receptors. Nature 1988; 331: 91–4
   PubMed Web of Science ®Google Scholar
• Evans R M. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889–95
   PubMed Web of Science ®Google Scholar
• Kliewer S A, Umesono K, Mangelsdorf D J., et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D signalling. Nature 1992; 355: 446–9
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D J, Borgmeyer U, Heyman R A., et al. Characterisation of three RXRs genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329–44
   PubMed Web of Science ®Google Scholar
• Umesono K, Murakami K K, Thompson C C., et al. Direct repeats as selective response elements for thyroid hormone, retinoic acid, and vitamin D, receptors. Cell 1991; 65: 1255–66
   PubMed Web of Science ®Google Scholar
• Schrader M, Bendik I, Becker-Andre M, et al. Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem 1993; 268: 17830–6
   PubMed Web of Science ®Google Scholar
• Reichel H, Koeffler H P, Norman A W. The role of vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 980–91
   PubMed Web of Science ®Google Scholar
• Elder J T, Fisher G J, Zhang Q Y., et al. Retinoic acid receptor gene expression in human skin. J Invest Dermatol 1991; 96: 425–33
   PubMed Web of Science ®Google Scholar
• Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D, receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230–6
   PubMed Web of Science ®Google Scholar
• Taimi M, Chayeau M T, Cabanne S, et al. Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D, on the differentiation of the human monocytic cell line 11937. Leuk Res 1991; 15: 1145–52
   PubMed Web of Science ®Google Scholar
• Dore B T, Uskokovic M R, Momparler R L. Induction of differentiation in HL-60 myeloid leukaemia cells by retinoic acid and vitamin D analogs. Proc Am Assoc Cancer Res 1992; 33: 2640
   Google Scholar
• Defacque H, Dornand J, Commes T, et al. Different combinations of retinoids and vitamin D, analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines. J Pharmacol Exp Ther 1994; 271: 193–9
   PubMed Web of Science ®Google Scholar
• French L E, Ramelet A A, Saurat J H. Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin. Lancet 1994; 344: 686–7
   PubMed Web of Science ®Google Scholar
• Alirezai M, Dupuy P, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 1994; 30: 447–51
   PubMed Web of Science ®Google Scholar
• Bollag W, Ott F. Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas. Agents Actions 1970; 1: 172–5
   PubMedGoogle Scholar
• Robinson T A, Kligman A M. Treatment of solar keratoses of the extremities with retinoic acid and 5-fluorouracil. Br I Dermatol 1975; 92: 703–6
   PubMed Web of Science ®Google Scholar
• Peck L G. Topical tretinoin in actinic keratosis and basal cell carcinoma. J Am Acad Dermatol 1986; 15: 829–35
   PubMed Web of Science ®Google Scholar
• Marth C, Daxenbichler G, Dapunt O. Synergistic anti-proliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J Natl Cancer Inst 1986; 77: 1197–202
   PubMed Web of Science ®Google Scholar
• Frey J R, Peck R, Bollag W. Antiproliferative activity of retinoids, interferon a., and their combination in five human transformed cell lines. Cancer Leu 1991; 57: 223–7
   PubMed Web of Science ®Google Scholar
• Gullberg U, Nilsson E, Einhorn S, et al. Combinations of interferon-)' and retinoic acid or lot,25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937. Exp Hematol 1985; 13: 675–9
   PubMed Web of Science ®Google Scholar
• Petrini M, Dastoli M, Valentini P, et al. Synergistic effects of alpha interferon and 1,25-dihydroxyvitamin D3: preliminary evidence suggesting that interferon induces expression of the vitamin receptor. Haemalologica 1991; 76: 467–71
   PubMed Web of Science ®Google Scholar
• Majewski S, Szmurlo A, Marczak M, et al. Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination. Cancer Lett 1993; 75: 35–9
   PubMed Web of Science ®Google Scholar
• Majewski S, Marczak M, Szmurlo A, et al. Retinoids, interferon a, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RARa mediates the antiangiogeneic effect of retinoids. Cancer Lett 1995; 89: 117–24
   PubMed Web of Science ®Google Scholar
• Lippman S M, Parkinson D R, Itri L M., et al. 13-cis-retinoic acid and interferon a-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235–41
   PubMed Web of Science ®Google Scholar
• Nguyen T, De Forni M, Armand J P., et al. Remission complete d'un carcinome spinocellulare cutane traite par l'association interferon alpha 2a-isotretinoine apres echec des traitments habituels. Ann Dermatol Venereol 1993; 120: 827–9
   PubMedGoogle Scholar
• Kraemer K H, DiGiovanna J J, Peck G L. Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 1992; 19: 715–18
   PubMedGoogle Scholar